Are there any studies comparing cannabis with conventional treatments for AS? 

Direct AS treatment comparison studies between cannabis and conventional therapies like NSAIDs or biologics remain limited, though interest is growing. Most existing research focuses on individual case reports or broader reviews of cannabis in chronic pain management, rather than head-to-head trials. 

Nonetheless, early effectiveness data and anecdotal evidence suggest cannabis may support symptom relief, especially for sleep disturbances and chronic pain. What’s still unclear is how cannabis stacks up long-term against drugs designed to slow disease progression. Similarly, comparisons of side effect profile remain underdeveloped, with cannabis often showing fewer severe risks but more variation in patient experience. 

What We Know So Far 

Limited clinical trials 

Robust AS treatment comparison studies are still in development, with small-scale research showing promising early results. 

Effectiveness in symptom control 

Cannabis may rival some traditional treatments for pain, though not necessarily for inflammation reduction. 

Patient-reported benefits 

Real-world feedback continues to drive curiosity around cannabis, especially for those with resistance to standard therapies. 

Treatment accessibility 

Treatment costs for cannabis are typically out-of-pocket, while traditional medications are more often covered by insurance. 

Visit providers like LeafEase to explore current findings and expert perspectives on how cannabis fits into a comprehensive AS treatment comparison strategy. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Ankylosing Spondylitis and medical cannabis.